No retraction, correction or concern found when last checked on Oct 29, 2026.
Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants
Veronika Tchesnokova, Hemantha Kulasekara, Lydia Larson and 14 more
Journal of Clinical Microbiology · 2021 · CC BY
Abstract
We report that there is a recent global expansion of numerous independent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with mutation L452R in the receptor-binding domain (RBD) of the spike protein. The massive emergence of L452R variants was first linked to lineage B.1.427/B.1.429 (clade 21C) that has been spreading in California since November and December 2020, originally named CAL.20C and currently variant of interest epsilon.
Cited by papers we hold 8
- SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines · 2022No notice
- The Delta variant mutations in the receptor binding domain of SARS-CoV-2 show enhanced electrostatic interactions with the ACE2 · 2022Not checked
- A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations · 2022No notice
- SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern · 2021No notice
- Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy · 2021No notice
- The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape · 2021No notice
- Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination · 2021No notice
- SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.